Want to join the conversation?
Amit Singh of Jefferies asks for an update on revenue guidance and business wins. $CSRA said for the low end of the guidance, it needs to win about $150MM of new business. To get to the midpoint, $CSRA must win $250MM and for the high-end, it must win $350MM of business. $CSRA believes its business opportunities will help achieve its guidance.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?